Elotuzumab (HuLuc63)

by
Updated: Dec 3, 2009
Brand Name:  
Generic Name: elotuzumab
Code Name: HuLuc63
Company: Facet Biotech/Bristol-Myers Squibb
FDA Clinical Phase: 1/2

Description:

Elotuzumab (news), a monoclonal antibody, selectively targets glycoproteins that are highly expressed on myeloma cells but not on healthy cells. In the presence of elotuzumab, myeloma cells undergo cell lysis and death. Clinical trials are currently underway to examine the activity of elotuzumab in patients with refractory or relapsed myeloma.

Clinical Trials:
For a list of clinical trials studying elotuzumab for the treatment of multiple myeloma, see ClinicalTrials.gov.

Web site for elotuzumab: http://www.facetbiotech.com/pipeline/product/elotuzumab/

Related Articles: